Close Menu

droplet digital PCR

NEW YORK (GenomeWeb News) – Similar to human breast cancers, canine mammary tumors are beset by chromosome instability, researchers from Chronix Biomedical and the Institute of Veterinary Medicine at the University of Göttingen in Germany reported in PLOS One yesterday.

A team led by researchers at the Barcelona Biomedical Investigation Institute in Spain has used quantitative real-time PCR and droplet digital PCR to detect and quantify diminished levels of cell-free mitochondrial DNA in cerebrospinal fluid of patients with, or at risk of develo

Scientists from molecular diagnostics firm Chronix Biomedical and University Medical Center Göttingen in Germany have developed an assay to measure circulating cell-free graft DNA as an early indicator of organ transplant rejection.

Trovagene is using RainDance Technologies' RainDrop Digital PCR system to develop and eventually run a cell-free transrenal BRAF mutation assay out of Trovagene's CLIA lab, the companies said this week.

A group of researchers from Massachusetts General Hospital has developed a method using either BEAMing RT-PCR or digital droplet-based PCR to detect mutations associated with glioblastoma brain tumors in RNA extracted from extracellular vesicles released from these tumors into pa

Scientists from the University of California, San Francisco, and the California Institute for Quantitative Biosciences, or QB3, have published a study demonstrating how picoinjection can be used to precisely and efficiently add reagents to individual digital PCR reaction volumes

A flurry of recently published peer-reviewed papers has demonstrated the growing breadth and diversity of applications for Bio-Rad's QX100 Droplet Digital PCR system.

Bio-Rad is working with Elizabeth Blackburn, a researcher at the University of California, San Francisco School of Medicine and co-founder of Telome Health, to develop a sensitive and high-throughput digital PCR assay to measure telomerase activity in human cells, PCR Insider

It has been nearly a year since RainDance Technologies officially "launched" its digital PCR platform, RainDrop, by recruiting researchers to be part of an early-access program.

Monoquant, an Australian company spun out of Flinders University to commercialize molecular methods to monitor minimal residual disease in blood cancers, has developed a PCR-based DNA assay that can routinely detect one cancerous cell in 10 million normal cells in chronic myeloid

Pages

The Wall Street Journal looks into FamilyTreeDNA's handling of genetic genealogy searches by law enforcement.

In a point-counterpoint in the Boston Globe, researchers discuss the potential of gene editing to prevent Lyme disease, but also the pitfalls of doing so.

MIT's Technology Review reports that researchers hope to develop a CRISPR-based pain therapy.

In Science this week: atlas of malaria parasites' gene expression across their life cycles, and more.